Matches in Nanopublications for { ?s ?p "DDI between Toremifene and Dasatinib - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.